Juergen E Gschwend Selected Research

Juergen E Gschwend Research Topics

Disease

18	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 09/2002
15	Neoplasms (Cancer) 01/2020 - 09/2002
11	Urinary Bladder Neoplasms (Bladder Cancer) 02/2020 - 03/2005
4	Disease Progression 01/2017 - 12/2003
3	Neoplasm Metastasis (Metastasis) 12/2012 - 09/2002
3	Transitional Cell Carcinoma 08/2007 - 03/2005
2	Carcinoma (Carcinomatosis) 01/2020 - 01/2011
2	Residual Neoplasm 12/2005 - 11/2005
1	familial Prostate cancer 01/2017
1	Retinoblastoma (Glioblastoma, Retinal) 03/2016
1	Pulmonary Embolism 04/2015
1	Febrile Neutropenia 04/2015
1	Asthenia 04/2015
1	Pneumonia (Pneumonitis) 04/2015
1	Neutropenia 04/2015
1	Carcinoma in Situ 02/2015
1	Breast Neoplasms (Breast Cancer) 12/2012
1	Pain (Aches) 12/2012
1	Hematuria 05/2012
1	Urinary Bladder Calculi (Bladder Calculi) 05/2012
1	Renal Cell Carcinoma (Grawitz Tumor) 12/2011
1	Carcinogenesis 01/2011
1	Adenocarcinoma 04/2007
1	Hydronephrosis 03/2007
1	Lymphatic Metastasis 12/2006
1	Stress Urinary Incontinence 08/2006
1	Intestinal Diseases (Diseases, Intestinal) 08/2006
1	Renal Insufficiency (Renal Failure) 03/2005
1	Pre-Eclampsia (Preeclampsia) 12/2002
1	Urinary Tract Infections (Urinary Tract Infection) 12/2002
1	Acidosis 12/2002
1	Colorectal Neoplasms (Colorectal Cancer) 09/2002

Drug/Important Bio-Agent (IBA)

5	Prostate-Specific Antigen (Semenogelase)IBA 01/2017 - 05/2006
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 02/2004
3	Cisplatin (Platino)FDA LinkGeneric 01/2020 - 08/2007
3	Hormones (Hormone)IBA 04/2007 - 09/2002
2	palbociclibIBA 07/2019 - 03/2016
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2018 - 01/2011
2	Docetaxel (Taxotere)FDA Link 01/2017 - 04/2015
1	Mesylates (Mesylate)IBA 01/2020
1	NivolumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	linrodostatIBA 01/2020
1	MTOR InhibitorsIBA 01/2018
1	abemaciclibIBA 03/2016
1	abirateroneIBA 05/2015
1	Lenalidomide (CC 5013)FDA Link 04/2015
1	Prednisone (Sone)FDA LinkGeneric 04/2015
1	hypericinIBA 02/2015
1	Povidone (Crospovidone)IBA 02/2015
1	Diphosphonates (Bisphosphonates)IBA 12/2012
1	Zoledronic Acid (Zometa)FDA Link 12/2012
1	Nicotine FDA Link 05/2012
1	TOR Serine-Threonine KinasesIBA 01/2011
1	Small Interfering RNA (siRNA)IBA 01/2011
1	Mitogen-Activated Protein KinasesIBA 01/2011
1	Choline (Choline Chloride)IBA 10/2007
1	Gemcitabine FDA Link 08/2007
1	AntigensIBA 05/2007
1	AndrogensIBA 04/2007
1	Decitabine FDA Link 04/2007
1	Butyric Acid (Butanoic Acid)IBA 03/2007
1	FenretinideIBA 03/2007
1	NitratesIBA 05/2005
1	Drinking WaterIBA 05/2005
1	DNA (Deoxyribonucleic Acid)IBA 02/2004
1	Biomarkers (Surrogate Marker)IBA 12/2003
1	Cadherins (E-Cadherin)IBA 12/2003
1	Peptide Hydrolases (Proteases)FDA Link 12/2003
1	Metalloproteases (Metalloproteinases)IBA 12/2003
1	SodiumIBA 12/2002
1	Citric Acid (Citrate)FDA LinkGeneric 12/2002
1	PotassiumIBA 12/2002
1	HydrogenIBA 12/2002
1	Tumor Biomarkers (Tumor Markers)IBA 09/2002
1	alpha-methylacyl-CoA racemaseIBA 09/2002

Therapy/Procedure

13	Therapeutics 02/2020 - 02/2004
6	Prostatectomy (Retropubic Prostatectomy) 12/2022 - 10/2007
5	Cystectomy 01/2020 - 03/2005
3	Castration 01/2017 - 04/2007
2	Drug Therapy (Chemotherapy) 04/2015 - 03/2007
1	Lymph Node Excision (Lymph Node Dissection) 12/2023
1	Radiotherapy 12/2022
1	Neoadjuvant Therapy 01/2020
1	Transurethral Resection of Bladder 05/2012
1	Urinary Diversion (Ileal Conduit) 11/2011
1	Brachytherapy 10/2007
1	Adjuvant Radiotherapy 03/2007
1	Contraindications 08/2006
1	Renal Dialysis (Hemodialysis) 03/2005
1	Kidney Transplantation 03/2005
1	Cesarean Section (Caesarean Section) 12/2002
1	Antibiotic Prophylaxis 12/2002